Athena Countouriotis Biomarin Pharmaceutical Inc (BMRN) insider trading activity

Athena Countouriotis is Director of BIOMARIN PHARMACEUTICAL INC. Currently has a direct ownership of 6,900 shares of BMRN, which is worth approximately $427,938. The most recent transaction as insider was on May 21, 2024, when has been sold 4,720 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.9K

0% 3M change

216.51% 12M change

Total Value Held $427,938

Athena Countouriotis Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
May 21 2024	BUY Grant, award, or other acquisition	-	4,720 Added 40.62%	6,900 Common Stock
Dec 27 2023	BUY Grant, award, or other acquisition	-	2,180 Added 50.0%	2,180 Common Stock

Also insider at

TPTX

Turning Point Therapeutics, Inc.

President & CEO

PASG

Passage BIO, Inc. Healthcare

IOVA

IOVANCE BIOTHERAPEUTICS, INC. Healthcare

Director